| 臺大學術典藏 |
2020-04-28T07:25:14Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Hsu C.-Y.; Chen B.-B.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Chih-Hung Hsu;Cheng A.-L.;Shih T.T.-F.; Liang P.-C.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Huang Y.-H.; Lee K.-T.; Wang C.-C.; Chau G.-Y.; Lee W.-C.; Ting C.-T.; Lee P.-H.; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Chia-Hsien Cheng;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-04-10T12:51:25Z |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
Liang P.-C.;Ch'Ang H.-J.;Chiun Hsu;Tseng S.S.;Shih T.T.F.;Wu Liu T.; Liang P.-C.; Ch'ang H.-J.; Chiun Hsu; Tseng S.S.; Shih T.T.F.; Wu Liu T. |
| 臺大學術典藏 |
2020-04-10T12:51:22Z |
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
|
Chang Y.-T.;Chang M.-C.;Wei S.-C.;Tien Y.-W.;Chiun Hsu;Liang P.-C.;Tsao P.-N.;Jan I.-S.;Wong J.-M.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; Chiun Hsu; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-04-10T12:51:08Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Chen B.-B.; Shih I.-L.; Wu C.-H.; Chiun Hsu; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C. |
| 臺大學術典藏 |
2020-04-10T12:51:05Z |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Chen L.-T.; Shih T.T.F.; Liu T.W.; Chiun Hsu; Liang P.-C.;Ch’Ang H.-J.;Chiun Hsu;Chen L.-T.;Shih T.T.F.;Liu T.W.; Liang P.-C.; Ch’ang H.-J. |
| 臺大學術典藏 |
2020-04-10T12:51:04Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Chiun Hsu; Liang P.-C.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W. |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Chiun Hsu; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-10T12:16:14Z |
Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment
|
Tien Y.-W.; Cheng A.-L.; Liang P.-C.; YU-YUN SHAO; Lin Z.-Z. |
| 臺大學術典藏 |
2020-03-27T02:04:01Z |
Angiographic diagnosis of high-flow priapism with superselective transcatheter embolization and hematofibrinolytic therapy
|
Tsang Y.-M.; Kao-Lang Liu;Liang P.-C.;Tsang Y.-M.; KAO-LANG LIU; Liang P.-C. |
| 臺大學術典藏 |
2020-03-27T02:03:52Z |
Preoperative diagnosis of gastric tumors by three-dimensional multidetector row CT and double contrast barium meal study: Correlation with surgical and histologic results
|
Yuk M.-T.; Lee P.-H.; Shun C.-T.; Wong J.-M.; Chen B.-B.;Liang P.C.;Kao-Lang Liu;Hsiao J.-K.;Huang J.-C.;Wong J.-M.;Lee P.-H.;Shun C.-T.;Yuk M.-T.; Chen B.-B.; Liang P.C.; KAO-LANG LIU; Hsiao J.-K.; Huang J.-C. |
| 臺大學術典藏 |
2020-03-27T02:03:26Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
KAO-LANG LIU; Liang P.-C.; Chen C.-H.; Shih T.T.-F.; Hsu C.; Wu C.-H.; Shih I.-L.; Chen B.-B.; Chen B.-B.;Shih I.-L.;Wu C.-H.;Hsu C.;Chen C.-H.;Shih T.T.-F.;Kao-Lang Liu;Liang P.-C. |
| 臺大學術典藏 |
2020-03-27T02:03:21Z |
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
|
Liang P.-C.; Wu Y.-M.; Lee P.-H.; Hu R.-H.; Ho M.-C.; Ho C.-M.; Huang K.-W.; Wu C.-H.; KAO-LANG LIU; Lee B.-C.; Lee B.-C.;Kao-Lang Liu;Wu C.-H.;Huang K.-W.;Ho C.-M.;Hu R.-H.;Ho M.-C.;Wu Y.-M.;Lee P.-H.;Liang P.-C. |
| 臺大學術典藏 |
2020-03-26T06:54:22Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.; Lin T.-H.; Liang P.-C.; Chang W.-T.; Huang C.-H.; ANG YUAN; Wang A.-Y. |
| 臺大學術典藏 |
2020-03-25T03:28:14Z |
Pneumatosis intestinalis and hepatic portal venous gas after CPR
|
Lien W.-C.; Wang H.-P.; Chen W.-J.; Liang P.-C.; WEI-TIEN CHANG; Lai C.-F.; Chen W.-J.;Wang H.-P.;Lien W.-C.;Liang P.-C.;WEI-TIEN CHANG;Lai C.-F. |
| 臺大學術典藏 |
2020-03-25T03:28:02Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.; Lin T.-H.; Liang P.-C.; Chen S.-C.;Lin T.-H.;Liang P.-C.;WEI-TIEN CHANG;Huang C.-H.;Yuan A.;Wang A.-Y.; Wang A.-Y.; Yuan A.; Huang C.-H.; WEI-TIEN CHANG |
| 臺大學術典藏 |
2020-03-25T02:36:51Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
SHYR-CHYR CHEN; Lin T.-H.; Liang P.-C.; Chang W.-T.; SHYR-CHYR CHEN;Lin T.-H.;Liang P.-C.;Chang W.-T.;Huang C.-H.;Yuan A.;Wang A.-Y.; Wang A.-Y.; Yuan A.; Huang C.-H. |
| 臺大學術典藏 |
2020-03-23T08:17:37Z |
Pneumatosis intestinalis and hepatic portal venous gas after CPR
|
Chen W.-J.; Chen W.-J.;Wang H.-P.;WAN-CHING LIEN;Liang P.-C.;Chang W.-T.;Lai C.-F.; Lai C.-F.; Chang W.-T.; Liang P.-C.; WAN-CHING LIEN; Wang H.-P. |
| 臺大學術典藏 |
2020-03-12T02:02:53Z |
Pneumatosis intestinalis and hepatic portal venous gas after CPR
|
Chen W.-J.;Wang H.-P.;Lien W.-C.;Liang P.-C.;WEI-TIEN CHANG;Lai C.-F.; Lai C.-F.; WEI-TIEN CHANG; Liang P.-C.; Lien W.-C.; Wang H.-P.; Chen W.-J. |
| 臺大學術典藏 |
2020-03-12T02:02:42Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Chen S.-C.; Lin T.-H.; Liang P.-C.; WEI-TIEN CHANG; Huang C.-H.; Yuan A.; Chen S.-C.;Lin T.-H.;Liang P.-C.;WEI-TIEN CHANG;Huang C.-H.;Yuan A.;Wang A.-Y.; Wang A.-Y. |
| 臺大學術典藏 |
2020-03-11T05:22:40Z |
The Significance of Endograft Geometry on the Incidence of Intraprosthetic Thrombus Deposits after Abdominal Endovascular Grafting
|
Wu I.H.; Liang P.C.; SHU-CHIEN HUANG; Chi N.S.; Lin F.Y.; Wang S.S. |
| 臺大學術典藏 |
2020-03-10T03:29:53Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Shen W.-C.;Liang P.-C.;Wu J.-F.;Hsu C.-T.;Chen H.-S.;Huey-Ling Chen; Shen W.-C.; Liang P.-C.; Wu J.-F.; Hsu C.-T.; Chen H.-S.; HUEY-LING CHEN |
| 臺大學術典藏 |
2020-03-06T08:25:06Z |
Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis
|
Liang P.-C.; YUNG-MING JENG; Yang C.-Y.; Tien Y.-W.; Wong J.-M.; Chang Y.-T.; Jan I.-S.; Chang M.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:06Z |
Quantification of hepatic steatosis: A comparison of the accuracy among multiple magnetic resonance techniques
|
Shih T.T.-F.; Lai H.-S.; Hu R.-H.; Liang P.-C.; Hsu C.-Y.; YUNG-MING JENG; Ho M.-C.; Wu C.-H.; Wu C.-H.;Ho M.-C.;Yung-Ming Jeng;Hsu C.-Y.;Liang P.-C.;Hu R.-H.;Lai H.-S.;Shih T.T.-F. |
